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Among the many new diagnostic procedures being
developed today, myocardial imaging by means of radionuclide
scanning promises to be a valuable tool for studying coronary
artery disease. Under investigation in major centers, it is
hoped that it might achieve widespread availability in the
future. Work in this field during the past two decades has
involved physiological experiments in the laboratory and
initial patient trials with qualitative analysis of the
defects seen in pathologic states. A study was undertaken at
Yale-New Haven Hospital to determine whether the next step,
quantitative interpretation, might be feasible. Prior to
undertaking this study, an extensive review of previous ex
perience with radionuclide myocardial imaging was completed.
This review provided insight into the present capabilities
and future directions of this relatively new technique.
Before describing the results of the present investigation,
the historical development and current uses of myocardial
imaging will be considered in detail.
The evaluation of the patient with clinical symptoms
suggestive of coronary artery disease requires careful study
of many parameters of cardiac function. Technological aids
to assist the physician range from the easily obtained
electrocardiogram and standard laboratory enzyme determinations
to the invasive procedures of cardiac catheterization and
angiocardiography. At one end of the spectrum, the risks are
minimal and the tests benign; the other end can be fraught
with difficulty and substantial risk. Coronary arteriography
allows definition of the location and extent of obstruction or
stenosis in the coronary vascular system but provides little
information about blood flow and perfusion of vascular beds
distal to the obstructed segments. The left ventriculogram
allows visualization of the ventricular cavity during systole
and diastole as well as documentation of valvular or congenital
abnormalities .
Reported (1) complications of catheterization and
angiocardiography include cardiac arrest, myocardial infarction,
cerebral vascular accident, ventricular or atrial arrhythmia,
hemopericardium, cardiac tamponade, perforation of atrium,
ventricle, or coronary vein, enzyme elevation, loss of
arterial pulse secondary to vessel thrombosis, hemorrhage at
the arteriotomy site, venous spasm, embolus, pulmonary infarc
tion, localized phlebitis and thrombosis, infection, excessive
blood loss, pyrogen reaction, arteriovenous fistula, pneumo
thorax or pleural effusion secondary to perforation of the left
ventricle and lung, major anaphylactic reactions from contrast
media, hypoxia due to reduction in effective orifice area of
a severely stenotic valve by catheter, and ventricular fibril
lation due to improper grounding. A recent review of 800
catheterizations at Yale-New Haven Hospital (2) revealed seven
catheterization related deaths and twelve catheterization related
myocardial infarctions. Granted that cardiac catheterization
and angiocardiography can be 'relatively safe' procedures in
experienced hands, the above list of potential problems
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emphasizes the careful consideration that must precede the
clinical decision to perform these techniques. If sufficient
information for the patient's evaluation could be obtained
with a less hazardous procedure, it would be advisible to
select that option. In addition to an initial evaluation, the
need exists for a means of achieving patient follow-up after
medical or surgical treatment without exposing the patient to
unnecessary risks. Because of these needs, attempts have been
made to develop noninvasive techniques such as echocardiography
and radionuclide imaging.
Imaging techniques involving the administration of
radioactive tracers which are extracted by the myocardium permit
the noninvasive or atraumatic acquisition of data that could
previously only be achieved with invasive catheter techniques.
In addition, physiologic measurements and observations such as
the determination of coronary blood flow, not readily obtainable
by other modes of study are now possible with modification of
clinical scanning procedures. The technique usually involves
the injection of a radioactive tracer which is initially cleared
and concentrated by cardiac muscle. After intravenous or
intracoronary administration of the radioactive tracer, the
myocardium is 'scanned' or 'imaged' and a radioisotopic picture
of myocardial uptake as determined by flow, viability, scar,
and myocardial metabolism is obtained. Qualitative interpretation
of the images follows in which the normal pattern is believed
to be represented by a homogeneous distribution of radioactivity,
while abnormal patterns are represented by heterogeneous dis-
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tributions , corresponding to decreased or increased uptake
depending on the radioactive tracer.
The recent reviews by Zaret et a_l. , (3,4) illustrate
the refinements made in myocardial imaging techniques since
Love (5) reviewed the 'state of the art' ten years ago. Myo
cardial imaging offers a possible direct means of determining
the extent of myocardial involvement in coronary artery disease.
With specific techniques, one may estimate coronary blood flow.
In the future, it may be possible to estimate infarct site,
size, extent, and presence of associated asynergy.
These last mentioned indices provide an insight into
the immediate risk and long term prognosis of the patient with
myocardial infarction. Similar clinical questions may be asked
in regard to the patient with angina pectoris. Imaging
techniques can then, if modified, be applied to answering these
questions. It is important to know the location and degree of
coronary arterial stenoses, as well as the amount of myocardium
served by these vessels.
Coronary blood flow and oxygen consumption per gram of
tissue are usually normal at rest in patients with moderate
coronary artery disease, but during exercise, many patients
have an inadequate increase in coronary blood flow with re
sultant metabolic abnormalities such as the release of lactate,
phosphate, and potassium from the myocardium and with a
significant decrease in the oxygen saturation of coronary sinus
blood. Stress may increase the myocardial oxygen consumption
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beyond the limited ability of the coronary circulation to
increase the flow. By administering the radioactive tracer
during exercise induced stress, one might hope to identify an
ischemic zone.
Myocardial scanning could then serve as a screening
device to select those patients with extensive reversible
ischemia for vigorous therapy. Stress-testing with radio
nuclides provides additional objective evidence in those patients
whose prior evaluation has been hampered by equivocal exercise
tests and laboratory data. In patients with both previous
myocardial infarction and angina pectoris, localization of
ischemia to the peri-infarction region or to a zone of myo
cardium supplied by a different major coronary artery might
influence a decision of whether to pursue medical or surgical
therapy .
Radionuclide myocardial imaging thus aims to complement
the clinical evaluation of the patient by noninvasive means
with data that was not available previously. Techniques
ideally, should be simple enough to be performed in most
hospitals and not require an excessive amount of sophisticated
or expensive equipment. Radioactive tracers employed should
have a relatively short half-life in order that repeated studies
could be performed without excessive interim delay, have an
energy suitable for imaging with both the scintillation camera
and rectilinear scanner, and not be prohibitively expensive.
Now that the general principles of radionuclide myocardial
-5-
imaging have been mentioned, attention will be devoted to
a discussion of the radioactive tracers.
Radionuclides utilized in myocardial imaging may be
divided into categories according to their physiologic
characteristics. Some radionuclides are taken up by function
ing myocardial tissue. These include potassium and its ana
logues, cesium, rubidium, and thallium, as well as nitrogen
as ammonium ion, labelled fatty acids ,toluidine blue, labelled
norepinephrine, and bretylium. Nonfunctioning myocardial mass
will appear as a 'cold spot'. It is not possible to distinguish
between recent or old infarction or temporary ischemia during
stress. It can only be stated that that portion of myocardium
does not extract the tracer. Presumptive diagnosis would
depend on clinical or historical evidence.
Another category includes those radionuclides which
are taken up only by tissue that has recently undergone infarc
tion. These include mercury, iodine, gallium, and technetium-99m
labelled tetracycline, pyrophosphate, and glucoheptonate.
Acutely infarcted myocardial mass appears as a 'hot spot' . This
category is unique in that the presence of increased radio
activity is specific for the acute process of infarction
-
areas
of old infarction or transient ischemia will not extract these
tracers.
The final category involves those agents which are
dependent on regional myocardial blood flow. These include
krypton, xenon, and labelled macroaggregated albumin. Among
these are some tracers which must be administered by intra-
coronary or intra-atrial injection.
-6-
These categories will be considered in order with a
discussion of each radionuclide.
ni i r>A 129 134m
CESIUM (1-:ilCs, -LJ^Cs, Cs, Cs)
Cesium, an analogue of potassium, behaves similarly
in regard to some of its physical properties and is noted to
be extracted by heart muscle. Four isotopes of cesium have
been studied and found to have various degrees of clinical
applicability.
131Cs 134Cs
Carr et_ a_l. (6,7) first demonstrated the potential
clinical applications of myocardial accumulation of radio
nuclides in 1963. In preliminary work with dogs, infarcted
areas were shown to contain a mean of 19.6% less cesium than
normal myocardium. Autopsies confirmed that the 'cold spot'
seen on the in vivo scan corresponded to the site of infarction,
131
The work was done using 1.0-2.5 mCi of Cs intravenously.
Cesium-134 was also investigated, but studies with cesium-131
appeared to be of higher quality.
ion
Collier et al. , (8) concluded that the Cs scan was
not able to detect occlusion of the right coronary artery, con
firming that the right ventricle did not show up on the image
and indicating the difficulty in documenting infarction of
the inferior wall of the left ventricle. It was noted that
the resting scan could not differentiate between normal and
stenotic but not occluded coronary arteries. In this series,
correlation between angiographic data and scan was 6 7%.
Further work was done to improve the interpretation of the
images. (9) Using 'phantoms', it was demonstrated that
-7-
lesions can be well visualized if on the anterior wall of the
left ventricle and that attenuation of counts from bony
structures overlying the chest wall was insignificant. Good
quality scans were obtained with low energy collimators.
Clinical work in 13 patients showed that it was possible
to visualize left ventricular myocardium in the living patient,
detect defects, and impose no harm or risk. (7) Himes et al. ,
(10) in a series of 104 patients demonstrated that all of
their patients with an abnormal electrocardiogram ranging from
left ventricular hypertrophy to bundle branch block to
ischemia to myocardial infarction had an abnormal scan
- the
degree of abnormality was variable. McGeehan et al. , (11) in
their series reported that eight out of nine patients with
clinical evidence of myocardial infarction and scanned after
131
1.25 mCi of intravenous CsCl had perfusion defects on scan,
the site of which correlated well with electrocardiographic
and cinearteriographic data.
Other clinical applications of the 131cs scan include
the demonstration of large perfusion defects in patients with
cardiac tumor (fibroma) (12) , ventricular aneurysm (13) , and
idiopathic cardiomyopathy (14) . Inoh (14) concluded that it
was difficult to visualize a lesion of the posterior wall of
the left ventricle or of the entire right ventricle. In
addition it was suggested that high uptake of cesium-131
without 'cold spots' in hypertrophic obstructive cardiomyopathy
reflected the increased thickness of the left ventricular wall.
The most recent large scale investigation of cesium-131
was a study of 600 myocardial infarcts. (15) Simultaneous
cardiac blood pool evaluation was performed with mIn which
permitted the appreciation of the size of the ventricular
cavity and eliminated the influence of ventricular volume
increase on an altered myocardial scan. Of 323 anterior wall
infarctions, all scans depicted abnormalities and 65% showed
discrete 'local blank' areas. Of 235 posterior wall infarctions,
all showed a hypoactive area.
129Cs
Recent work has involved cesium-129- (16) Romhilt
et al. , (17) studied 50 patients with 3-4 mCi of intravenous
129
Cs which remains in the myocardium after a single dose and
permits serial imaging. It was felt that the lower gamma
energies permitted better resolution with less collimator
septum penetration than by the higher gamma energies of
potassium-43.
An attempt at quantification of myocardial infarction
was made by Ashare et a^. , (18) in 1974. Using intravenous
cesium-129 and experimental infarctions in dogs, they correlated
autopsy evidence with composite percentage involvement of
myocardium made from four views recorded by an Anger gamma
camera. The results demonstrated good agreement and it was
felt that this type of analysis would be useful in human studies.
-9-
134mcs
Preliminary canine studies with cesium-134m began in
1973. (19) The radiation dose was reduced two- to threefold
with the oral administration of Prussian blue, which inhibits
reabsorption of cesium from the gut. Further work may be
continuing with this isotope but as yet no patient trials
have been reported.
pfi 84 82 81
RUBIDIUM (bbRb,
°
Rb, Rb , Rb)
Rubidium, an element in the same periodic group as
potassium, has similar physical properties. It was theorized
that it would behave similarly in physiologic situations.
Among the isotopes of rubidium, four have been under investiga
tion as 'cold spot' radionuclides.
86Rb
Rubidium was investigated as a tracer of potassium in
the attempt to provide information about myocardial metabolism.
(20-22) The majority of body organs, including the heart,
concentrated exchangeable rubidium to a degree which paralled
their concentration of potassium. Love et al. , (22) suggested
a 'lag phenomena' of higher rubidium specific activity in the
myocardium. This was thought due to a 'lag' in the loss of
the isotope from the myocardium rather than continued gain
after specific activity had been reached. Love and Burch
(23-25) in another series of papers in 1967 demonstrated that
drugs known to affect coronary blood flow (decreased by vaso-
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pressin and increased by L-norepinephrine) affected the uptake
of rubidium-86 by the myocardium as a whole in the manner which
would be expected if 86Rb uptake were dependent on the rate of
coronary blood flow- In addition, the mean extraction of Rb
by the left ventricle was 45% faster than by the right ventricle
and atria. In dogs receiving norepinephrine, uptake was more
rapid in the inner portion of the left ventricle than the outer.
Calculations showed that two thirds of the Rb was removed in
one circulation. The myocardial extraction of rubidium was
again related to the rate of coronary flow by studies in animal
myocardium. (26-27) Another comparison of regional uptake in
various regions in the myocardium showed higher concentration
in the left ventricle. (28) An early study by Carr et al. , (29)
indicated that the concentration of tracer after 100-500
microCi of intravenous °°RbCl was at least 15% less in infarcted
than in normal myocardium.
Using rubidium, Moir and DeBra (30,31) suggested that
forward flow in the endocardium is somewhat less than in epi-
cardium under normal pressure flow conditions. Higher uptake
of isotope from the left ventricle was attributed to increased
uptake from the cavity rather than increased flow to endo
cardium. Love and O'Meallie (32) confirmed the relationship
between the rate of rubidium-86 uptake and the rate of coronary
blood flow. However, Love et a_l. , (33) two years later
described possible errors in this calculation with high carbon
dioxide tensions or low oxygen saturation. Metabolic factors
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as well as flow govern cation extraction. In the range
of
pC02=2O-6O mm Hg and O2 saturations greater than 75%,
the
rubidium clearance was felt to be a valid index of coronary
flow. Durgs such as angiotensin, 1-norepinephrine, dipyridamole
and digoxin had no significant effect on the prediction of
flow from clearance. Also noted was an inverse relationship
between the rate of coronary blood flow and the fraction of
rubidium-86 removed from the blood during one passage through
the myocardium. The heart muscle extracted almost all of the
tracer at low rates of flow but only slightly more than half
at the fastest rates.
Further studies continued using rubidium-86 to calculate
myocardial blood flow in different portions of the myocardium.
Diffusion from endocardial surfaces and transport by luminal
vessels were demonstrated to contribute to 8^Rb uptake (34)
and the higher extraction of rubidium by the left ventricle
was again demonstrated. (35) Both perfusion and diffusion
by intracavitary blood were mechanisms responsible for 8^Rb
uptake .
Love and Burch (25) attempted some of the first clinical
trials with rubidium-86 using methods developed from canine
studies. Patients with and without coronary artery disease
(CAD) were selected. The plasma concentration of 8^Rb averaged
57% higher in seven subjects with angina pectoris and was
ascribed (perhaps questionably) to low cardiac output. The
coronary blood flow rate was estimated from the rate of
-12-
myocardial potassium exchange and proved to be significantly
different in the two groups:
with CAD 4 3±15 ml/100 gm myocardium/minute
without CAD 90±45 ml/100 gm myocardium/minute
Bennish et a_l. , (36) described initial increases in
isotopic rubidium clearance after nitroglycerine administered
to 13 patients with angina pectoris.
In 1969, three-dimensional balsa wood models were
added in conjunction with computer analysis of the rubidium
scan. (37) Further improvement of computer interpretation
was attempted by mathematical analysis and color coding three
years later. (38) Rubidium-86 is now being utilized in
radiocardiographic determinations of cardiac output. (39)
84Rb
Cohen et al. , (40) studied a positron emitter, rubidium-84,
which results in the production of two gamma photons directed
180 degrees apart. A coincidence counting technique with two
pairs of detectors is utilized. One pair is in front and
back of the precordial area, the other pair is placed sym
metrically on the right side of the chest. The activity of
the myocardium alone is expressed by the difference of radio
activity between the left and right sides of the chest. It
was felt that this technique had several advantages; (a) the
elimination of background counting technqiues arising from
natural radioactivity, cosmic rays, and contaminants. (b)
it is supposedly five times as efficient. (c) the counting
rate is in direct proportion to the tissue content.
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Futher investigation of rubidium-84 was performed
using certain drugs. (41,42) Nitroglycerine, intensain (a
chromene derivative) and isoptin ( a beta blocking nitrile
derivative) significantly increased myocardial flow in individuals
without coronary artery disease but failed to show an increase
in patients with diseased coronary vessels.
82
Rb
Another isotope of rubidium, ultrashort-lived 82Rb was
described to have certain distinct advantages: (a) high uptake
in heart as compared to skeletal muscle, (b) low radiation
exposure, (c) the possibility of quick repeat studies (half-
life is 1.25 minutes), (d) the ability to use the scintillation
camera. Only animal work has been reported. (43)
81Rb
The latest isotope of rubidium was described in 19 74 by
Martin et al_. , (44) The radionuclide °lRb decays with a half-
life of four hours 34 minutes to Slm^r which decays with a
half-life of 13 seconds (thus becoming a mini-generator) to
8 1
stable Kr. The amount of rubidium- 81 within a tissue after
administration changes only slowly, whereas its daughter,
being an inert gas, mixes uniformly with the tissue and is
removed from it at a rate dependent on the perfusion of the
tissue. Good quality images in 15 patients (comparing favor
ably with previous K images in these same patients) showed
perfusion defected at the site of transmural myocardial
infarctions .
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The most recent work with rubidium- 81 attempts to
validate the 81Rb image as a diagnostic tool in cardiac exam-
81
ination. The Rb image was compared with the coronary arterio
gram, the left ventriculogram and 99mTc or 13ll labelled
albumin particle images. (45) Defects in rubidium-81 images
correlated well with pathology seen by the angiographic methods.
Another study utilized the 81Rb radionuclide in association
with stress testing and correlated the results with angiography.
(46) Of eight negative scans, there was one false negative.
Of 15 positive scans, there was no false positive. Notable
was the fact that four of these 15 patients had false negative
exercise electrocardiograms.
Advantages with this isotope include more favorable
although not ideal photon energies, desirable short half-life,
and economical production. In addition, the decay scheme
suggests the possibility for noninvasive measurement of
8 1
coronary blood flow by comparing myocardial activity of Rb
decay with that of its daughter 81mKr.
POTASSIUM (42K, 43K)
Potassium, one of the most important intracellular
cations, plays an important role in myocardial metabolism.
Differences in both intra- and extracellular concentrations
and flow rates can reflect pathologic as well as drug induced
changes. For these reasons, attempts were made to study
potassium kinetics in the normal and diseased heart. Initial
work involved potassium-42 and continued with a more useful
isotope, potassium-43 .
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The first demonstration of the myocardial accumulation
of radioactive potassium was accomplished in 1941. (47,48)
These early animal studies of K were not followed up until
the mid-1950 's when work began on the kinetics of potassium
transfer in the left ventricle (49) and calculation of regional
blood flow using the fractional uptake of potassium-42. (50)
In an important study of 1964, Donato et a_l. , (51)
demonstrated that the myocardial clearance of potassium could
be obtained by precordial counting after a single intravenous
injection of KC1 or RbCl. The lack of systemic differences
between clearance of these two tracers confirmed previous
observations that they are handled in a similar fashion by
the myocardium. The myocardial clearance of potassium was
calculated. This reflects flow per gram of myocardium and
not the total coronary blood flow. Every unit of myocardium,
regardless of how well it is perfused, contributes to the pre
cordial counting rate in variable proportions determined by
the efficiency of the counting method.
Love et al. , (52) attempted to locate areas of reduced
coronary blood flow with 42K. Adjacent areas were compared
in animal experiments , with one normal zone and one zone
supplied by experimentally induced coronary stenosis. Further
investigations correlated findings on potassium-42 myocardial
scans with coronary angiography- (5 3-55) These controlled
studies indicated that poorly perfused areas on scans ('cold
spots') correlated well with areas supplied by stenotic major
coronary vessels. The best correlation occurred with a lesion
-16-
of the left anterior descending artery which resulted in
anterior and/or apical ischemia and/or infarction.
43
K
The 1970 's ushered in a new isotope, potassium-43 .
Cooper et al_. , (56) reported recording data from 43K scans on
tape for quantitative analysis , although no mention was made
of the analytical results. It was mentioned that the size
of the defects could be determined. Holman et a_l. , (57)
demonstrated that potassium washout after the first minute in
normal man was monoexponential with a half-life of 30 minutes.
Thus the first circuit extraction of radiopotassium after intra-
coronary injection provides a high target to background ratio
and offers a potential method of evaluating regional myocardial
perfusion and viability. Canine experiments to estimate the
amount of radioactivity in the heart after the first circuit
extraction as determined by the scintillation camera showed
reasonable agreement with findings at autopsy. (58)
The physical properties of potassium-43 were considered.
(59,60) The only contaminant is 42K (less than 5%). 43K
decays with seven different gamma radiations to 43Ca. The best
results with scanning resulted from summing the high (590-
610 KeV) and low (370-390 KeV) energy peaks. It was suggested
that, should computer calculations be desirable, maximum;
resolution could only be retained by use of counts from the high
energy peak alone.
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An important contribution to the interpretation of the
myocardial image made using potassium-43 came from the demon
stration that the central cold area corresponded to the left
9 9m
ventricular cavity. This was accomplished with Tc-albumm
blood pool studies superimposed on the K scan. (61) Potassium-
43 was distributed predominantly in the left ventricle and septal
muscle. The much thinner right ventricle and atria were less
well defined and areas of infarctions were seen as 'cold spots'.
Initial physiologic studies were followed by clinical
trials which proved to be successful. Gorten (62) in his series
of 20 patients treated for myocardial infarction showed that all
except one had abnormalities on scan. The scans correlated well
with electrocardiographic, enzyme, arteriographic, and ventriculo
graphy data. The evaluation of patients with coronary artery
disease undergoing surgery for myocardial revascularization was
studied both pre- and postoperatively. (63,64) Definite im
provement in the scan in regard to perfusion was described six
to 14 days following surgery. Other investigators made three-
dimensional representations of potassium-43 distribution from
the scan matrix. (65) Technetium-9 9m was injected and sub
tracted to eliminate noncardiac radioactivity.
The most recent work with potassium-43 has come from
the laboratory of Zaret and his co-workers. In 1973, 43
patients were studied at rest and during maximal treadmill
exercise. (66,67) As mentioned in the introduction, stress
may increase the myocardial oxygen consumption beyond the
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limited ability of the coronary circulation compromised by
arteriosclerotic changes to increase the flow. Stress testing
has been shown to be an effective method of producing ischemia
under controlled conditions and at the same time of recording
43
the electrocardiographic changes. In 12 normal subjects, K
distribution was homogeneous both at rest and during exercise.
In 13 out of 15 patients with previous myocardial infarction
studied at rest, regions of decreased radionuclide accumulation
corresponded to the anatomic location of the infarct. In 16
out of 19 patients with angina pectoris, regions of relatively
43
decreased K accumulation were identified when the tracer
was administered during exercise but were not present at rest.
These zones of relative hypoperfusion corresponded to regions
supplied by angiographically stenotic coronary arteries.
Another clinical study evaluated false positive elec
trocardiographic exercise tests. (6 8) Twelve patients meeting
the criteria (greater than one mm ST segment depression during
graded maximal treadmill exercise testing in the absence of
exercise induced chest pain) to be designated as having positive
tests were studied. In previous evaluations, coronary arterio
graphy, left ventriculography, and hemodynamic evaluation
revealed no significant abnormality. These patients had no
clinical coronary disease. Nine out of the 12 patients were
exercised with potassium-43 being administered intravenously
during a time when the abnormal ECG changes were present.
Myocardial images in these patients all showed a homogeneous
pattern of radioisotope distribution. These results are con-
-19-
trasted with findings in patients with coronary artery disease
in whom reproducibly demonstrable abnormal regions are seen
during exercise-induced ischemia.
In another evaluation of aortocoronary bypass surgery,
Zaret et al_. , (69) confirmed the capability of K scans in
assessing the results of the procedure. The patients were
divided into two groups. Scans which showed improvement or
normal uptake correlated well with 13 out of 16 patent grafts
seen on postoperative angiography. Scans which had not improved
or worsened correlated with patients who had experienced intra
operative infarction, those with significant distal coronary
disease, and those with occluded grafts. Since then, computer
analysis has been applied to the evaluation of serial K scans
after revascularization surgery. (70) Results demonstrate
higher uptake after surgery.
Recent work with potassium-4 3 has shown that there is
no significant difference between labelled macroaggregated
albumin (discussed below) studies and 4^K images, although the
authors felt that defects were more discretely outlined by the
MAA. (71) The location of the defect correlated well with
abnormal left ventricular contraction. Another clinical study
investigated 10 patients with left bundle branch block. (72)
All patients were asymptomatic, had good exercise tolerance
and showed decreased uptake in the septum at rest and during
stress. Five patients had normal coronary vessels and normal
biplane left ventriculography. The authors suggest that ab-
-20-
normal cellular metabolic uptake of potassium-43 in the region
of the septum may be present which also might account for the
conduction abnormality.
In a quality control investigation, the diagnostic
accuracy of potassium-43 scans was compared with clinical,
laboratory, electrocardiographic, and catheterization data in
85 patients. (73) Cardiologists interpreted all information
except the K scan. Nuclear medicine specialists interpreted
only the scan. The agreement between the two modes of inves
tigation was significantly high. The degrees of accuracy were
as follows: in previous myocardial infarction 88% agreement;
in acute infarction 94%, in patients with coronary artery disease
but without infarction 89%. It was concluded that myocardial
imaging with potassium-43 is sufficiently accurate for clinical
use in detecting the presence and location of myocardial infarcts
although acute and chronic stages cannot be distinguished.
Coronary arterial narrowing does not directly cause 43K ab
normalities. Static imaging abnormalities depend on the presence
or absence of focal ischemic necrosis or fibrous tissue replace
ment.
Work now is being directed at refinement of data in
terpretation and quantification of the amount of scar tissue.
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CESIUM, RUBIDIUM, POTASSIUM: A COMPARISON
Several studies contrasted the radioisotopes of cesium,
rubidium, and potassium in myocardial scanning. (74,75) In
one circulation, the following percentage of isotope is extracted:
71% K, 65% Rb, and 22% Cs . Cesium has the slowest uptake and
longest intracellular retention. Rubidium is cleared from the
arterial blood at a rate closely related to the rate of coronary
flow- The high extraction of potassium makes it an extremely
suitable indicator from coronary flow measurements. All radio
nuclides currently available for myocardial perfusion studies
are cyclotron or accelerator produced and also have relatively
short half-lives. This factor and their high cost limit their
widespread application. Potassium-43 also has the disadvantage
of having energies that make imaging difficult. Cesium, rubidium,
and potassium thus far have shown the best applicability for
imaging the myocardium. Other radioisotopes, now to be
discussed, are undergoing investigation.
,ioq 201
THALLIUM (-L^^T1, Tl)
Thallium as the thallous ion is analogous to potassium
ion. The myocardium was visualized with Tl in 1970 but no
further work was reported. (76) Recent studies with 2^1t1,
however, have been most encouraging. Strauss et al. , (77)
43
compared thallium-201 uptake with K images in 30 mice. Blood
clearance and myocardial uptake were similar. Scans in dogs
after ligation of the left anterior descending coronary artery
using both radionuclides were performed. It was felt that
-22-
thallium-201 produced better quality images although both were
acceptable.
In addition, thallium has low energy gamma emissions
suitable for imaging with the conventional scintillation
camera and a desirable half-life of 74 hours.
NITROGEN (13N)
A preliminary report on the use of radioactive nitrogen
as NH3 or NH4+ as a scanning agent appeared in 1972. (78)
Imaging is possible by both gamma ray and positron methods.
Clinical trials reported in patients with myocardial infarctions
1 3
after the administration of 10 mCi of NH3 resulted in definite
defects in some scans while others were equivocal. (79,80) The
images did not appear to be of ideal quality. More promising
results were obtained with the use of a specially designed
multicrystal positron camera. (81,82) Experimental infarcts
in dogs showed definite defects in uptake.
The technique was further modified by taking scintigrams
at uniformed space angles to permit tomographic imaging and
three dimensional reconstruction of nuclide distribution in
the heart. (83) In a study of five patients, defects corres
ponded to angiographically demonstrated areas of coronary
occlusive disease.
The short half-life (9.96 minutes) of nitrogen-13
limits clinical usefulness to institutions with cyclotrons.
A definite disadvantage occurs when this radionuclide is used
in smokers, in whom lung trapping of NH3 may obscure the cardiac
image.
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In a new application, nitrogen-13 was attached in the
amide position of an amino acid ,asparagine . (84,85) Pre
liminary reports of canine experiments demonstrate that the
myocardial extraction after intravenous administration is
significantly higher than that reported for the alkaline metals,
although the reason for uptake is obscure. It was suggested
that asparagine might play some unknown role in myocardial
metabolism.
LABELLED FATTY ACIDS
Radioiodinated fatty acid bound to albumin was studied
as an imaging agent in 1965. (86-88) Oelic acid labelled
with iodine-131 was administered intravenously in a dosage of
5.7 microCi / kilogram. Reports showed concentrated radio
activity in the ventricles due to incorporation of labelled
fatty acid into myocardial triglyceride and phospholipid.
Necropsy studies of canine and patient myocardium revealed a
higher distribution of radioactivity in healthy myocardium
than in infarcted muscle. Forty-two patients, nine with a
recent myocardial infarction were studied. Of the nine, four
scans demonstrated definite and two probable 'cold spots'.
Difficulty arose with the poor resolution of the images
and attempts to use fatty acids were abandoned until 1973.
Better results were obtained with technetium-9 9m (89) and
iodine-131 (90) as the labels. Decreased uptake in experi
mentally infarcted canine myocardium was seen after adminis
tration of 10 mCi of 99mTc-oleic acid. Other animal experi-
ments with -LOXI-oelic acid in 25% human serum albumin show
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similar results with high quality scans and gamma camera images.
Two advantages of labelled oleic acid are the relatively low
cost and around the clock availability. Due to more promising
results with other radionuclides however, labelled fatty acids
are no longer undergoing widespread investigation.
TOLUIDINE BLUE
Radio-iodinated toluidine blue was introduced to myo
cardial imaging in 1973. (91) A significant selective uptake
of -LOXI- toluidine blue was noted when preceded by a priming
dose of the unlabelled stable compound toluidine blue. Infarcts
were visualized as 'cold spots'. Some caution must be exercised
since one patient had transient ST segment depression after the
administration of 3.5 mg/kg of toluidine blue.
LABELLED NOREPINEPHRINE
Hc-Norepinephrine has recently been described, but as
yet has not undergone extensive study. (92) A positron emitter
with a half-life of 20.3 minutes, it has a rapid uptake in
the heart after an intravenous bolus and remains there long
enough to permit imaging. Being carrier free, l-'-C-Norepinephrine
is considered to be free from the physiologic action of the
parent drug, norepinephrine. The heart and heart cavity are
reported to be adequately visualized in the dog. The radiation
dose is low and acceptable.
BRETYLIUM
Radio-iodinated bretylium analogues (RIBA) were
reported to be potentially
useful for myocardial scanning. (93)
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The normal uptake of RIBA in heart muscle is sufficient to
obtain good delineation of myocardium and the ratio of radio
activity in normal versus infarcted tissue is sufficiently
high to permit demonstration of infarcts by scintigraphy.
Iodine-125 was used in these animal studies.
The next approach to the evaluation of coronary artery
disease involves the utilization of radionuclides which accumulate
in the acutely damaged area, producing the so-called 'hot spot.'
As might be expected from a substance that accumulates in an
area of infarction, the uptake is not specifically flow
related. Collateral circulation, inflammatory response, as
well as the altered metabolism in the zone of infarction may
play a role in the myocardial extraction of these agents.
'Hot spot' scanning techniques represent a theoreti
cally useful approach to myocardial imaging and have now
undergone sufficient clinical trials to be considered a
valuable asset in the evaluation of cardiac disease. This
method offers an opportunity to view the infarction as a
positive image and should allow differentiation of old from
recent infarction. It should be emphasized that transiently
ischemic areas are not revealed by 'hot spot' scans. Mercury,
iodine, gallium, and 99mTc-labelled tetracycline, pyrophosphate,
and glucoheptonate will be discussed.
MERCURY (203Hg)
Carr et al. , (94,95) injected 700 microCi of 203Hg-
labelled chlormerodrin (Neohydrin) intravenously into dogs.
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Experimentally created infarction showed up as areas of in
creased radioactivity on scan. One criticism of this work
involves the way transient ischemia was defined. Release of
coronary occlusion after one hour should not be considered
ischemia. In most cases, myocardial infarction will have
occurred and perhaps be extended into a hemorrhagic infarct by
release of the occlusion. Attempts to extend this work to man
proved to be unsuccessful, perhaps due to inadequate amounts
of tracer or to technical difficulties. (96)
Another report of intravenous radioactive mercury in
swine indicated that the hot spot on scan correlated well with
the pathological observation of the location and extent of the
experimental infarct. (97,98) The area of damage could be
visualized on scan before replacement with fibroblastic tissue.
Malek et al. , (99,100) in 1967 found that 5-6 microCi/kg of
Mercurascan 20 3 or Brommercurascan 20 3 was superior to Neohydrin
in accumulating (to a greater extent) in damaged myocardial
tissue .
Mercury-20 3 attached to fluorescein was used to detect
experimental infarcts in dogs. (101) Ramanathan et al. , (102)
in 1971 concluded that the ratio of radioactivities between
diseased and normal tissues were too low to permit scanning of
an infarct. The mechanism of action of the mercurials is
thought to be due in part to interaction with sulfhydryl groups
of partially or completely denatured proteins. Unfortunately
results in patient trials have been disappointing despite
promising animal work. In addition, the radiation dose to the
kidney is a distinct disadvantage.
-27-
IODINE (131I)
Attempts to visualize the myocardium with radioiodine
alone were not rewarding. Preliminary work in 1959 demon
strated that although myocardial infarcts and injured skeletal
muscle concentrate iodine more than comparable normal tissue,
the differential uptake per unit weight was not of sufficient
magnitude to permit detection by external in vivo methods . (103)
In a study by Dreyfuss et a_l. , (104) one year later, 23 patients
with recent myocardial infarctions all showed increased uptake
in infarcted areas after intravenous administration of 100
microCi of iodine-131. Counts were more concentrated after a
few days, but were first noticeable 48 hours after injection.
131
The rate of removal of Na I was shown to be influenced
by changes in the coronary circulation. (105,106) In patients
with coronary artery disease, the disappearance of radio
nuclide from the myocardium was variable. One of the last
studies of Na I done by Mason et al. , (107) concluded that
radioiodine was useless as a scanning agent. The concentration
of radioactivity over the left precordium 24 hours after oral
or intravenous administration was due to radioiodine concentrated
in the cardia of the stomach.
GALLIUM (67Ga)
Gallium-6 7 was recently reported to concentrate in
regions of experimental canine infarction was well as in neoplastic
and inflammatory tissue. (108-110) Difficulty in interpretation
of the gallium myocardial scan arises from the concentrations
of significant activity in adjacent structures, specifically
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the liver, vertebrae, and mediastinal lymph nodes. These
problems will have to be circumvented before gallium can achieve
clinical applicability.
TETRACYCLINE
Malek et al. , (111) demonstrated in 1963 that tetra
cycline accumulated around an area of myocardial infarction will
fluoresce. This work formed the basis of 'hot spot' imaging
with tetracycline. The use of technetium-99m labelled tetra
cycline was reported in renal imaging (112) and applied to the
myocardium by Holman et a_l. , (113) Canine experiments with
10-15 mCi of "Vc-tetracycline injected intravenously in dogs
25 hours after coronary occlusion and imaged 24 hours later
demonstrated that the radioactive tracer was homogeneously
distributed throughout the infarct (in a concentration five to
eight fold greater than in normal myocardium) .
In clinical studies, 28 patients were scanned after
99m
the intravenous administration of 20 mCi of Tc-tetracycline .
(114,115) In all 14 patients with clinical evidence of acute
myocardial infarction and in two out of five patients with
equivocal evidence, scintigrams were abnormal. Scintigraphy
revealed negative scans in nine patients in whom an acute
lesion failed to evolve. The peak activitiy on scan appeared
one to three days after the clinical onset of chest pain.
An extension of the same work is now attempting to
correlate the scan with monophasic action potentials and
epicardial electrocardiographic maps. (116) Excellent




Technetium-99m labelled stannous pyrophosphate has
lately received much acclaim as a 'hot spot' radioactive tracer.
Pyrophosphate is incorporated into the crystalline structure
of hydroxyapatite found within the mitochondria of irreversibly
damaged myocardium. Promising clinical work was reported. (117-
99m
120) Intravenous administration of 15 mCi - 5 mg Tc-stannous
pyrophosphate was performed in 2 3 patients, 15 of whom had an
acute myocardial infarction by history, electrocardiogram, and
enzymes. Of 11 scanned three to five days post myocardial
infarction, all were positive. Two out of four scanned seven to
10 days post infarction were positive. Scintigrams were negative
in eight patients with angina pectoris but not infarction.
The most recent clinical studies indicate that labelled
pyrophosphate is indeed a safe rapid method of identifying a
myocardial infarction in its early stage. Willerson et al . , (121)
studied 100 patients suspected of having a myocardial infarction.
Of 55 patients without any laboratory evidence of infarction,
99m
none of the Tc-stannous pyrophosphate images were positive.
Of 45 patients with positive enzyme and electrocardiographic
evidence, 39 had positive scans within six days of the onset of
infarction. Six patients imaged more than six days post
infarction had negative scans.
Gould et al_. , (122) used mTc-stannous polyphosphate,
a related agent, to study 46 patients with various cardiac
pathology. Clinical groups were arranged by category: (a)
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Normal patients, pericarditis, and rheumatic heart disease
-
no cardiac activity on scan. (b) Stable A.S.H.D.
- faint
ill-defined desnity in the anterior or inferior left ventricle.
(c) Alcoholic cardiomyopathy
- faint diffuse activity in an
enlarged heart. (d) Acute myocardial infarction
-
an intense
discrete focal activity of characteristic shape and location.
Imaging with labelled pyro- or polyphosphates was
applied to patients with pre-infarction angina. (123) In one
patient there was increased activity, but not intense enough
to be considered infarction. This patient was sent for re
vascularization surgery. In another patient whose image was
diagnostic of infarction, surgery was deferred.
This tracer is safe, inexpensive, and universally ob
tainable. It is rapidly cleared by the kidneys so that little
or no blood pool is present in the heart at one hour unless
renal disease is present. It presents an advantage over
labelled tetracycline, which labels the liver and makes it
difficult to visualize diaphragmatic infarcts. Scanning must
be performed within six days of infarction. Disadvantages
include bone uptake and the necessity of waiting 24 hours after
intravenous administration of tracer for optimal imaging.
GLUCOHEPTONATE
Another "hot spot' radioactive tracer appeared for the
first time in 1974. (124) Technetium-99m labelled glucohep-
tonate accumulates in acutely infarcted canine myocardium. The
ratio of activity in infarcted versus normal tissue is sufficiently
high to potentially permit demonstration of infarcts by imaging.
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It remains to be evaluated in man.
The discussion thus far has considered agents that
accumulate in areas of viable or acutely infarcted myocardium
after intravenous injection. Myocardial extraction with these
radionuclides is a function of myocardial viability, metabolism
and scar as well as of flow. The final category of radioactive
tracers involves distribution dependent primarily on coronary
blood flow. In contrast to the relatively noninvasive method
of administration of 'cold spot' and 'hot spot' radionuclides,
flow dependent inert gases such as krypton and xenon, and
labelled macroaggregated albumin must be injected via catheter
directly into the coronary arteries or (in one case) into the
atrium.
KRYPTON
Myocardial blood flow was measured by the use of an
8 5
inert gas, krypton-85 by Herd et al_. , (125) in 1962. Kr was
injected into chronically implanted coronary artery catheters
and counted with an external scintillation detector. An im
portant study by Ross et. a_l. ,(126) involved the measurement of
myocardial blood flow in animals and man by the determination
of precordial radioactivity after selective injections of
krypton-85 and xenon-133 directly into the coronary arteries
following coronary arteriography. The accuracy of the radio
active gas measurements was established in the canine experiment
by comparison with coronary blood flow measured simultaneously
by rotameter .
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Further work by Cohen et al. , (127) with krypton-85
given as a single rapid injection into the left ventricular
cavity measured coronary flow using the Kety equation. The
Kety equation is based on the assumption that the rate of
exchange of a gas between blood and tissues is limited by the
rate of blood flow alone and not by diffusion. With this
method, measurements were made of left and right coronary flow
and found to be similar. (128)
Johansson et al. , (129) studied blood flow in ischemic
myocardium after intracoronary administration of krypton-85.
Recent work has dealt with quantitative indices of tissue per
fusion as measured by Rb decay into "^Kr and Kr , and was
discussed under rubidium. (130)
XENON
Regional myocardial perfusion was assessed qualitatively
by Cannon et. al . , (131,132) using another inert gas, xenon.
18-25 mCi of xenon-133 was infused into the left anterior des
cending or circumflex coronary arteries of the dog and washout
curves were calculated. Regional perfusion was reduced after
surgical constriction of the vessels. Further work delineated
the properties of this chemically inert, physiologically
inactive gas. Xenon is of small molecular size, lipid soluble,
and highly diffusible. Significant recirculation is absent.
Advantageous is the short half-life and low gamma energy. The
blood - myocardial tissue equilibrium of xenon is almost
instantaneous. The inert gas leaves heart tissue almost entirely
via venous drainage. It has the disadvantage of less than optimal
resolution.
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In two excellent studies, Cannon et al. , (133,134)
measured regional perfusion in man with and without coronary
artery disease. Intracoronary injections of 20-25 mCi of xenon-133
was followed by multiple crystal scintillation camera imaging.
Scintiphotos showed the arrival and washout of isotope from
various regions of myocardium. Counts per area per unit time
were determined by computer and flow rates per unit area were
calculated. Perfusion rates were greater (in normal individuals)
in the left ventricle than in the right ventricle or atrium,
again confirming earlier work. Local capillary flow rates
were depressed throughout the myocardium of patients with diffuse
coronary artery disease. With localized disease, flow rates
were subnormal only in discrete regions. Coronary artery
disease was thus shown to be associated with heterogeneity of
local myocardial perfusion rates. In addition, it was demon
strated that radiographically significant vascular pathology
of the right or left coronary artery may be associated with
significant reductions of myocardial capillary perfusion in
the region supplied by the diseased vessel.
Pachinger et a_l. , (135) had several criticisms of xenon-133.
The major problem was that flow was not uniform throughout the
heart and that catheterization of the coronary arteries was
required. This method however, can separate right and left
coronary circulation and can measure regional and collateral flow.
LABELLED MACROAGGREGATED ALBUMIN
Initial imaging with macroaggregated albumin following
coronary injection was reported by Ueda et al. , (136). In
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canine studies, using 50 microCi of iodine-131 labelled MAA
particles (40-60 microns) , regional blood flow in order of
quantity to region was determined: posterior wall of the left
ventricle >apex of the left ventricle, right ventricle, septum>
left atrium> right atrium. Quinn (137) in 1966 noted transient
premature ventricular contractions and T wave inversion after
intracoronary injection of radioiodine macroaggregates in dogs.
There was no evidence of myocardial damage, however, and the
electrocardiogram returned to normal 15 minutes later. Further
studies attested to its safety. (138-142) The authors used
10-60 micron MAA particles labelled with 200-800 microCi of
99iti 131
Tc or 30-150 microCi of I, which were then injected into
the coronary artery. Experimental infarcts showed up as 'cold
spots'. Studies in human subjects with heart disease resulted
in good quality scans and demonstrated areas of hypoperfusion.
No effects on electrocardiogram or blood pressure monitoring
were observed. There were no clinical signs of myocardial
ischemia during the procedure.
As particle size increased, it was reported that coronary
flow and contractile force decreased. (143) Microembolization
of radioactive particles can be utilized to visualize myocardial
perfusion patterns with an acceptable margin of safety as long
as the number of particles is kept to a minimum and the con
sistency is carefully controlled.
Color scintigraphy was added to MAA imaging in 19 73.
Color-coded scans in 400 patients reflected the uptake of radio
active tracer by well perfused areas in contrast to diseased myo
cardium. (144) .
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A new carrier, human albumin microspheres, instead of
macroaggregated albumin, was recently used without any signifi
cant change in blood pressure, heart rate, serum CPK , or
electrocardiogram. Intracoronary administration of 16-30 micron
microspheres labelled with 0.5-1.0 microCi of technetium-99m
was accomplished in 33 patients. (145) Some consider this
technique to be superior for the following reasons: (a) particle
size is uniform and consistent from batch to batch. (b)
99m
labelling with Tc is rapid and easy. (c) higher specific
activities can be obtained, thereby reducing the number of
particles needed for each image. (d) an ultrasonic mixer can
be used to assure complete dispersion of particles prior to
injection. The main disadvantage of this technique is that
it requires intracoronary administration. In addition to the
necessity of catheterization, the problem of 'streaming' is
encountered. If a catheter tip is misplaced, spurious images
may result from misdirection of the stream of particles.
The latest investigation involved 49 patients studied
at rest and during stress with technetium-9 9m and indium-113m
labelled MAA. (146) Stress was achieved by coronary injection
of Hypaque M, which increased coronary flow four to five fold.
In 10 patients without coronary artery disease, all had normal
rest and stress images. Thirty-seven out of 39 patients with
coronary disease had abnormal rest and/or stress images.
Eighteen of these patients without myocardial infarction had
abnormalities only during stress. Twenty-one of these patients with
myocardial infarction had abnormalities at rest and 16 had greater
defects during stress.
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Investigation of myocardial imaging techniques has
involved many radionuclides, some of which have proven to be
more practical than others. Of the 'cold spot' category, those
agents presently undergoing the most widespread trials are
cesium-131, cesium-129, rubidium-81, and potassium-43. Current
studies indicate that the use of thallium-201 might prove to
be advantageous because of its low energy, desirable half-life,
and good quality images. In the 'hot spot' group of radionuclides,
technetium labelled tetracycline and pyrophosphate have shown
the best clinical applicability thus far. Utilization of the
primarily flow dependent radioactive tracers has been limited
by the necessity for invasive techniques. However, if it has
already been determined that catheterization and angiocardiography
are indicated in a patient, the use of an agent such as labelled
macroaggregated albumin might be considered an adjunct procedure.
The ideal radionuclide for each category has not yet
been determined. The best scanning agent available today may be
replaced by cheaper, more readily available tracers that have
more favorable imaging energies and resolution. Nevertheless,
the specialist in cardiovascular nuclear medicine today still
has several radionuclides, although somewhat limited by inherent
technical problems, from which to select an agent that will provide
the desired information. Areas of viable myocardium or of acute
infarction can be highlighted. A combination of 'cold spot'
and 'hot spot* tracers can be used simultaneously with the aid
of dual probe scanning devices which can separate impulses from
the different energy peaks electronically. (147)
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Potassium-4 3 was selected for the present study
because it is presently one of the.most effective agents for
visualizing functional myocardial mass. Previous studies
have demonstrated the ability to qualitatively distinguish areas
of hypoperfusion corresponding to areas of transmural myocardial
infarction or to areas of transient ischemia during stress.
Theoretical aspects of this radioactive tracer will now be
discussed in further detail.
CHARACTERISTICS OF POTASSIUM AND OTHER THEORETICAL CONSIDERATIONS
The potassium-4 3 radionuclide used in this study is
described by the manufacturer as follows: Potassium-43 for
Myocardial Imaging contains no carried added KCl in sterile
apyrogenic 0.9% saline. The radionuclide composition at
calibration time is: 4-*K 1 mCi /ml ± 0.2 mCi / ml.
K<0.1 mCi / ml. Absorbed radiation dose was calculated for
3K using the absorbed fraction method and the following assump
tions: no excretion of radioisotope, effective half-life equals
physical half-life, the administered activity is instantaneously
and uniformly distributed in the intracellular space of the body,
which is taken as 50 liters or 50 kilogram in a 70 kilogram man.
The results of these calculations of absorbed radiation dose
43 . .
when 1 mCi of K was administered is as follows: total body
0.81 rad, marrow 0.91 rad, ovaries 0.92 rad, testes 1.12 rad.
To this date, after approximately one thousand studies, there have
not been any adverse effects of potassium-4 3 reported.
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Potassium is well suited for myocardial imaging because
of rapid clearance. Within a minute of injection, the tracer
is almost completely distributed within the myocardium and remains
in the left ventricular wall in a comparable distribution which
can be imaged for approximately one hour. Unlike particulate
microspheres, whose distribution of potassium is dependent as
well upon intact cell membrane ATPase function which maintains
transmembrane electrochemical gradients of sodium and potassium.
It is also dependent on the low intracellular cation pool.
Cold areas on the image represent areas of non- or
hypoperfusion and nonuptake . One cannot distinguish infarction
from ischemia by merely viewing the cold spot. If an area which
appears as a cold spot during an exercise test, takes up tracer
during a resting study, then and only then can it be attributed
to ischemia. The demonstration of cold spots attributable to
transmural scar is due to altered or nonfunctioning metabolic
processes in a greatly reduced myocardial cellular
mass in the
infarcted region and the replacement of viable tissue by
acellular collagen scar. The blood flow related distribution of
tracer is only a secondary effect.
As mentioned, abnormal zones of decreased radioactivity
concentration have not been readily demonstrable in patients
with angina pectoris, a finding which should not be unexpected.
During the resting pain-free state,
viable myocardial regions
supplied by stenotic major coronary
arteries receive adequate
perfusion, either from antegrade
flow past a high grade but not
total coronary occlusion, or from retrograde flow associated
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with intercoronary collateral vessels. Differences in perfusion
between normal vascular beds and those transiently ischemic
during periods of increased myocardial oxygen demands are not
readily apparent at rest.
By combining exercise stress testing, a well established
means of safely inducing angina pectoris, with 43r precordial
scanning, one can image transiently ischemic regions. The tracer
equilibrates with myocardial intracellular potassium stores
under the acute pathophysiologic condition of transient myo
cardial ischemia. The image reflects the ischemic state at
the time of injection even though imaging occurs at a time
when the patient is quite stable, is no longer experiencing
chest pain, or electrocardiographic changes, and myocardial
oxygen demands are not excessive.
Under conditions of maximal exercise, in response to
increased myocardial oxygen requirements, coronary blood flow
can increase up to threefold. Increase in flow is presumably
greatest in regions supplied by normal coronary arteries and
will be relatively less or even absent in regions supplied by
vessels with significant fixed obstructions. Therefore, the
difference between the absolute quantity of potassium-43
available for exchange in myocardial capillary beds beyond
arterial obstructions and that available in beds supplied by
normal coronary arteries is maximal during exercise.
In addition, experimental myocardial ischemia results
in an efflux of myocardial potassium, and during angina pectoris,
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a net loss of potassium from the myocardium is reflected by a
greater than normal increase in the quantity of potassium
present in coronary sinus blood. Thus, during exercise induced
angina pectoris, potassium-43 may be extracted with decreased
efficiency by ischemic regions as compared to normal zones, and
may be lost more rapidly from the intracellular space once it
is extracted. The net result is an abnormal distribution of
tracer.
PURPOSE OF THIS STUDY
Current concepts of coronary artery disease involve
determination of the viability of the myocardium in patients
with angina pectoris and in those with previous myocardial in
farction. Initial evaluation consists of obtaining the history
and physical examination. Chest pain, dyspnea, and exercise
intolerance (if not due to other organ pathology) among other
symptoms usually reflect altered cardiac status. Some abnormali
ties may be detected by careful phsical examination, however, it
must be emphasized that some patients with significant coronary
artery disease do not manifest any overt symptoms or signs of
cardiac disease until the cardiovascular system is severely com
promised. Clues to heart disease from the electrocardiogram
include nonspecific changes, ischemic changes, arrhythmias,
bundle branch block, and of course, new or old myocardial in
farction. Exercise stress testing by a variety of methods may
produce ischemic changes
on the electrocardiogram. Relief of
anginal symptoms within
several minutes with a trial of nitro
glycerine is also suggestive of coronary artery pathology. All
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of these procedures can be accomplished easily and provide a
basis for further investigation.
To achieve objective evaluation of those patients sus
pected of severe coronary artery disease, cardiac catheterization
and angiocardiography are utilized. Definition of coronary
artery structure and stenosis, visualization of left ventricular
contraction, physiologic measurements of pressure and saturation
and extrapolation of volumes allows objective evaluation of
cardiac viability. The reasons for seeking noninvasive means
of obtaining similar information have already been discussed
at length. More recently, epicardial mapping by electrocardiogram
(14 8, 149) and serial CPK enzyme studies (150) have attempted to
measure infarct size, but a discussion of these methods is beyond
the scope of this report.
Infarct size, its location, and contribution to
ventricular contraction are crucial factors in prognosis and
therapy. Radionuclide myocardial imaging has been shown to
provide qualitative information on infarct size and location.
This study attempts to quantify this information. Since ejection
fraction and therefore cardiac output are dependent on ventricular
volume and ventricular contractility, any segment of ventricular
wall that is contracting poorly or not at all, whether due to
myocardial infarction or other cardiomyopathy, will adversely
affect cardiac performance. A strategic location of a myocardial
infarction, especially if on the anterior wall, is also a factor
in compromising cardiac performance. Thus the size and site of
myocardial infarction are extremely important determinants of
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cf myocardial viability. Attempts to quantify the extent of
nonviable tissue and relate it to cardiac performance may allow
more accurate evaluation of the patient.
Previous studies have involved qualitative visual
assessment of the radionuclide image and correlation with gross
angiographic or clinical features. Although as yet qualitative
in approach, the potential use of these techniques to quantify
infarct size and ischemic myocardial regions is apparent. This
report describes initial experience with, a preliminary quantifi
cation of resting potassium-4 3 myocardial images in patients
following transmural myocardial infarction and correlates the
size and location of the regional 4^K defect with the site and
extent of local left ventricular contraction abnormality assessed




The 15 patients comprising this study were referred for
angiographic and radionuclide evaluation at least two months
following a documented transmural myocardial infarction. Clinical
referral had been prompted by either post infarction congestive
heart failure, angina, or both. The initial diagnosis of acute
myocardial infarction was made on the basis of typical chest pain,
characteristic evolutionary serum enzyme elevations and the
development of new Q waves of at least 0.04 seconds in at least
two standard ECG leads. The only criteria for inclusion in this
study were documentation of transmural myocardial infarction
and technically acceptable angiographic and radionuclide studies.
During the compilation of the above study group, four additional
43
patients were evaluated and not included due to inadequate K
images or ventriculograms, technically unsuitable for quantitative
analysis. The average age was 59 years with a range from 31 to
64 years. At the time of study, ECG localization of prior
infarction and hence residual transmural scar, involved the
anterior wall in six patients (anteroseptal in three, antero
lateral in two, and the entire anterior wall in one) , inferior
wall in four, both anterior and inferior walls in four, and in
one patient ECG-anatomic correlation was obscured by newly
developed left bundle branch block. Twelve patients were
receiving propranolol, ten patient digoxin, seven long acting
nitrates, and five a diuretic. (Table 1 and 2) .
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RADIONUCLIDE TECHNIQUE
Potassium-43 myocardial imaging was performed following
the intravenous injection of one mCi of the radionuclide. Po
tassium-43 was administered following a twelve hour fast, and
with the patient in an upright position. This procedure has
been shown to reduce splanchnic blood flow, and resultant
hepatic and gastric 4^K accumulation. Imaging was performed
with a rectilinear scanner (Picker Magnascanner 500) with a
five inch crystal and a 31 hole Picker model 2112 collimator.
In all studies, the collimator was positioned just above the
chest wall. A 0.34-0.70 MeV window was employed. Scanning
was accomplished with an approximate count density of one
thousand with standard contrast enhancement of 40% count rate
differential. Scans were obtained in anterior and 40-50 degree
left anterior oblique positions. Data was simultaneously re
corded in two ways : the familiar radionuclide scan recorded
on photographic film, and as a 'dot image' on teledeltos paper.
(Figure 1) The dot image is generated electrostatically by a
stylus which is attached to the moveable carriage on the end
opposite the crystal detector. The stylus records a dot on
the sensitive teledeltos paper when a preset amount of activity
(128 or 256 cpm) is encountered. As the detector moves back
and forth across the precordium, the dot image which can be
readily quantitied is described. The special orientation of
the dot image is exactly the same as the photographic scan,
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and by employing constant fixed spatial references, the two
presentations of myocardial radionuclide distribution could be
superimposed. A translucent grid of 10 x 12 mm rectangular
spaces was overlayedatop the dot image and the number of dots
and hence radioactivity in each region was counted. This
allowed a simple quantification of the visualized 43K left
ventricular myocardial distribution.
Potassium-4 3 data was analyzed independent of knowledge
of the angiographic or clinical findings. A qualitative
assessment of the scans was made as to whether K myocardial
activity was normal (homogeneous) or whether 'cold' regions of
relatively decreased radionuclide concentration existed (abnormal) .
Outlines of the left ventricular images in both views and the
cold spot defects were drawn. Because of the potential geometric
problem of increased left ventricular cavity size contributing
to an abnormal image pattern, a region of decreased activity
was not considered abnormal because of regional decreased myo
cardial uptake unless the abnormality extended to the outer
border of the myocardial image. Only images in which cardiac
and hepatic activities wereseparable were considered adequate
for evaluation. In each instance, the margin of a potassium-43
defect was taken as the point of sharpest demarcation between
'hot' and 'cold' areas on the photographic scan. The total
area of the myocardial image and defect in each view were
measured by planimetry and the area in each view designated
percent potassium-43 hypoperfusion (% 43r HP) . The fractional
defect size was then averaged for the two view. The traced
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outlines of the myocardial image were related to the grid dis
tribution of the dot image in each patient. (Figure 2)
CARDIAC CATHETERIZATION AND ANGIOGRAPHY
Hemodynamic and angiographic evaluation included right
and retrograde left heart catheterization and selective right
and left coronary cineangiography on 35 mm film in multiple
projections employing the techniques of Sones or Judkins .
Single plane left ventricular cineangiography was performed in
a 30 degree right anterior oblique position following injection
of 45-54 cc of Renograf f in-76 . In four patients, left ventricular
cineangiography was repeated following either epinephrine
infusion (two patients) or administration of nitrates (two
patients) .
Coronary arterial stenosis was considered significant if
greater than 70% of the luminal diameter was compromised. Left
ventriculograms were evaluated for the presence of dyssynergy
by both qualitative assessment and superimposition of traced
outlines of the end-diastolic and end-systolic cavitary silhouettes.
(Figure 3) Akinetic segments (segments sharing a common line
in systole and diastole) or dyskinetic segments (those showing
paradoxic systolic expansion) were identified from the superimposed
outlines and their length measured with a map measurer. (Figure 4)
This measurement was expressed as a percentage of the total end
diastolic circumference excluding the aortic valve plane. This
percentage was designated as percent abnormally contracting
segments (%ACS) . Ventricular volumes were determined by the method
of Greene et al., (151). (Table 2 & 3) (Figure 5)
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RESULTS
All 15 patients demonstrated angiographically signi
ficant coronary artherosclerosis with an average of 2.4 major
coronary arteries stenosed (range 1-3). In each instance,
location of the stenosed or obstructed coronary vessel or
vessels provided a suitable explanation for the site of infarction.
Contrast left ventriculography revealed abnormally contractile
akinetic or dyskinetic segments in every patient which again
corresponded to the clinical electrocardiographic location of
infarction. (In the one patient with left bundle branch block,
this was related to the post myocardial infarction ECG prior
to the development of the conduction disturbance.) Six of the
abnormally contracting segments were dyskinetic, the remaining
abnormalities represented segmental akinesis . The percent
abnormally contracting segments (%ACS) averaged 43% with a
range from 10% to 58%. In four patients further evaluated with
intervention left ventriculography, there was no "change in the
contractile pattern following either the infusion of epinephrine
or administration of nitrates. Ejection fraction averaged 0.44
(range 0.12-0.69). This correlated with the %ACS (r 0.76, p<0.001).
Left ventricular end-diastolic volume averaged 144 cc (range 37-
399 cc); cardiac output for the entire group averaged 3.8 liters
per minute with a range from 1.9 to 6.7 liters per minute; and
left ventricular end-diastolic pressure (LVEDP) averaged 19 mm
Hg (range 10-35 mm Hg) .
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On visual inspection, the 4^k myocardial images demon
strated significant areas of relatively decreased potassium-43
uptake in all patients. This is in direct contrast to studies
in normal subjects or patients with coronary artery disease
without myocardial infarction. Twenty-eight studies previously
performed in this laboratory served as controls. In twelve
normal subjects, K distribution was homogeneous both at rest
and during exercise. In sixteen patients with angina pectoris,
regions of relatively decreased K accumulation were identified
when the tracer was administered during exercise but were not
present at rest.
The anatomic sites of decreased uptake in the two views
were anterior wall (eight patients), anterior and inferior walls
(six patients) , and inferior and high lateral wall (one patient) .
In one case (#4) , the ECG findings did not correspond with the
results on the 4^K image or ventriculogram. Left ventricular
hypertrophy prevented recognition of anterior wall infarction.
Electrocardiographic findings failed to again recognize anterior
wall infarction in case #7. A possibility exists in this
patient, however, that the findings on 43K image and ventriculogram
were due to severe idiopathic or ischemic cardiomyopathy and not
due to infarction alone. In case #6, the potassium-43 image
failed to show an inferior defect to correspond with the inferior
hypokinesis seen on ventriculogram, however, the ECG similarly
failed to show inferior infarction. The inferior wall infarction
seen on ECG and inferior akinesis seen on ventriculogram in
case #13 were not accompanied by an inferior defect on the 43K
image. The fact that the radionuclide scan might miss an
-49-
inferior infarction has been documented and discussed in the
introduction. The scan is reported to demonstrate 6 0% of
inferior wall infarctions.
The defect size (% 43K HP) averaged 49% of the anterior
view image (range 25-66%) , 43% of the LAO view image (range
0-58%), with a mean defect percentage of 47% of the mean image
in both views (range 17-62%) . (One anterior view image in one
case was unsuitable for quantification.) The mean total area
of the AP image in the 15 patients was 5 8 cm2 with a range from
40 to 101 cm2.
The visualized defects in the photographic radionuclide
image were related to regional radioactivity concentrations as
measured from the dot image. Zones in which K radioactivity
distribution appeared homogeneous on the photographic film
were found to vary within 10% of the mean count rate in the region,
with most areas being within five percent of the mean count rate.
On the other hand, count rates in regions corresponding to zones
of decreased visual activity were at least 20% less than normal
regions, with a range from 20-40% reduction.
The site of the 43K imaging defect was as well related
qualitatively in each instance to both the ECG location of
infarction and the contrast ventriculography site of abnormal
segmental contraction. The extent of the 43K defect (% 43K HP)
was related to the extent of the segmental contraction abnormality
(%ACS) . The mean % 43K HP in both views as well as individually
in the anterior and left anterior oblique view correlated well
with the % ACS, the most significant correlation being between
mean % 43K HP and % ACS. (Figure 6)
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Mean % 4JK HP vs . % ACS r=0.77 p<0.001
ANT View % 43K HP vs. % ACS r=0.6 7 p<0.00 5
LAO View % 43K HP vs. % ACS r=0.5 4 p<0.0 5
The extent of 43K HP on the other hand correlated poorly
with ejection fraction, r=0.48; cardiac output, r=0.04; or
LVEDP, r=0.09.
As might be expected, the total area of the K image
in the anterior view reflects as well left ventricular dimensions
and could be related to left ventricular end-diastolic volume
(r=0.79, p<0.001). (Figure 7).
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DISCUSSION
Radionuclide imaging techniques hold much promise for
the future because of their general noninvasive nature and
their ability to describe physiologic parameters not easily
obtainable by other means. Myocardial extraction of a radio
nuclide such as potassium-43 is dependent on blood flow, regional
cell membrane function, and the size of the regional intracellular
cation pool available for exchange with the radioactive tracer.
The latter two factors are of prime importance in the case of
transmural myocardial infarction in which viable myocardial
tissue has been replaced by acellular scar tissue. Thus the
43
distribution of radioactivity on the K image should represent
regional viability and the extent of post-infarction scar
formation.
The purpose of this study was twofold: (1) to examine in
the post-infarction patient, the quantitative relationships
between the site and extent of the visualized defect obtained
with K myocardial imaging, and the site and extent of ventricular
scar formation as assessed by segmental left ventricular con
traction disturbances; and (2) to relate these visualized 43k
perfusion defects to a preliminary quantification of regional
radioactivity.
Pathologic correlation was not available in this study.
Nevertheless, it is reasonable to assume that the segmental
contraction abnormalities following transmural myocardial in
farction in the 15 patients investigated were due to scar
formation. In one recent study by Baltaxe et al. , (152) ,
histologic ventricular examination was accomplished in 21
patients who had undergone cineangiographic evaluation before
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death. Local areas of left ventricle were examined and the
percentage of contraction of each area compared to the percentage
of contraction obtained in identical areas from 10 normal ven
triculograms. In 51% of the ventricular segments, dysfunction
paralleled the presence or absence of fibrosis. In 42% however,
dysfunction more severe than the fibrosis was due to ischemia
or coronary steal. The need for differentiation may be aided
by intervention ventriculography.
Further support of the view that contraction abnormalities
in this present study were due to scar formation is the failure
to improve segmental contraction during intervention left
ventricular cineangiography. This technique, described by Horn
et al . , (153) in 1974, demonstrated that left ventricular ab
normalities could be improved or changed in certain cases with
the inotropic stimulus of epinephrine, suggesting residual
contractile ability. Epinephrine may differentiate between zones
of potentially functional cardiac muscle and frank fibrosis.
In four subjects who subsequently underwent aneurysmectomy, pre
operative lack of improvement with epinephrine correlated with
a pathologic diagnosis of fibrosis.
The correlation between the extent of radionuclide
perfusion defects and the extent of contraction abnormalities
is an initial step toward establishing the validity of the
radionuclide approach for the quantitative assessment of myo
cardial viability- Similar results might be expected in the
instance of acute myocardial infarction in which the immediate
assessment of the extent and location of the myocardial lesion
more critical. This however, remains to be proven, since in the
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acute stages of infarction, heterogeneity of potassium-43 uptake
would most likely have a different primary mechanism, dependent
on flow and local myocardial metabolism, rather than nonuptake
by acellular scar. Radionuclide imaging of acute infarction in
the coronary care unit with portable scanning devices may one
day provide a valuable assessment of myocardial viability at
that critical stage.
The total area of the radionuclide image in the anterior
view was shown to reflect left ventricular dimensions and was
related to left ventricular end-diastolic volume. A similar
relationship using chest roentgenographs was noted by Kazamias
et al . , (154) who related measurement of the left heart dimension
on chest roentgenograph to the left ventricular cavity dimension
measured at the time of left ventriculography.
After many physiologic studies and clinical trials,
potassium-43 has proven to be quite useful for myocardial imaging,
although not entirely satisfactory. Its widespread clinical
applicability is limited by high energy emissions which limit
imaging to the rectilinear scanner unless special collimation
is employed with the scintillation camera. Images may be less
than optimal without meticulous technique. Availability is
limited by its relatively short half-life, cyclotron or
accelerator production and high cost. As previously discussed,
alternative radioactive tracers such as isotopes of cesium,
rubidium, and thallium are currently under investigation. Each
isotope, however, does present
its own inherent technical
problems. Nevertheless,
the demonstration of phenomena with a
standard radionuclide such as potassium-43 should allow application
of similar principles to similarly acting radioactive tracers.
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Visualized defects of apparent reduced regional radio
activity were demonstrated by this study to be associated with
quantifiable regional decreased count rates. Defects can be
artifactually created or enlarged by variation of collimator
distance from the patient source, thus influencing the relation
ship between target and optimal focal depth of the imaging system.
Collimator distance was as close as possible to the chest wall
and held constant in the present study to avoid artifact.
Quantitative statements can be made in regard to defect size,
however interpretation must be made with the realization that
current resolution although satisfactory, is not ideal. Other
problems to be considered in the imaging technique include the
role that the motion and geometry of the heart play in the
imaging process. Radioactivity counts per unit area on the
radionuclide image are obviously functions of these two factors.
Advances in both instrumentation and collimator design,
application of the higher resolution scintillation cameras and
computer processing of data, will undoubtedly improve resolution.
Only one true false negative result was encountered in
this series of 15 patients with previous transmural myocardial
infarction. This case involved inferior wall infarction, in
which the radionuclide imaging technique is reported to be 60%
accurate. Several other pathologic states other than myocardial
infarction have been associated with abnormal images and may
result in false positive results. Among these include tumor,
aneurysm, idiopathic cardiomyopathy, bundle branch block, and
asymmetric septal hypertrophy , (155) all of which have been
discussed in the literature review. Finally, patients with
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congestive cardiomyopathy and enlarged ventricular cavities
and thin left ventricular walls can also produce an image
similar to that of myocardial infarction. A markedly enlarged
left ventricular cavity can produce a large central defect.
Defects in this study were considered in terms of infarction
only if they extended to the outermost margins of the radio
nuclide silhouette.
There are limitations in the assessment of segmental
contraction patterns in coronary artery disease from single
plane left ventricular angiography. Although motion of the
anterior, apical, anteroapical , and inferior walls are all
visualized, contraction of the septal and posterior walls
cannot be evaluated. For this purpose biplane angiography would
be helpful. Visualization of the left ventricle in two planes
was an important feature in the study of Feild et al. , (156) ,
In an investigation of left ventricular performance following
myocardial infarction, the relative size of an abnormally
contracting region of the ventricle was shown to be quantitatively
related to impairment of left ventricular function. A relation
was demonstrated between left ventricular end-diastolic pressure
and the relative size of the abnormally contracting segment.
Ejection fraction correlated well with the degree of myocardial
viability.
Radionuclide myocardial imaging has been shown to be of
significant value in the
evaluation of the patient with coronary
artery disease.
The ability to obtain physiologic information
by noninvasive means
is a major advantage in clinical medicine.
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As has been discussed, the technique is not without its limitations;
among these include difficulty in instrumentation due to unsuitable
energies, geometry, and motion; unsuitable half-life; accelerator
or cyclotron production; and high cost.
Until now, myocardial imaging with radionuclides has been
limited to qualitative analysis. The present study demonstrates
that imaging with radionuclide intracellular cations such as
potassium-43 appears to accurately and quantitatively reflect
the site and extent of scar formation in the left ventricle
following myocardial infarction.
Future large scale investigations are necessary to
confirm the validity of this quantiative approach. Application
to the acute myocardial infarction and to transient reversible
ischemia using exercise or stress methods should be studied.
Radionuclide imaging may thus provide a quantitative index of




1. Clinical Data - patient information
2. Qualitative Data - data from ECG, 43K image, ventriculogram
3. Quantitative Data - derived values from measurement
4. Chart of major 'cold spot' radionuclides
ABBREVIATIONS USED
ALMI - Anterolateral Myocardial Infarction
ASMI - Anteroseptal Myocardial Infarction
AWMI - Anterior Wall Myocardial Infarction
ECG - Electrocardiogram
IWMI - Inferior Wall Myocardial Infarction
LAD - Left Anterior Descending
LAE - Left Atrial Enlargement
LBBB - Left Bundle Branch Block
LCf - Left Circumflex
LVH - Left Ventricular Hypertrophy
NYHA - New York Heart Association
RAD - Right Axis Deviation
RCA - Right Coronary Artery
NOTE : Table 1
Patients 6, 9, and 14 were specifically known to
have lipid abnormalities. Serum cholesterol and triglycerides
were not measured in this hospital in the other patients.
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Figure 1. Simultaneous recording
of radioactivity counts per unit
area on photographic film and on teledeltos paper (top) .
The radionuclide image of the myocardium (lower left)
corresponds exactly to the grid quantification (lower right)
derived from the teledeltos paper. Cross-hatched grid
spaces represent maximum counts in areas of viable myocardium.
Single hatched grid spaces represent areas in which quantified
radioactivity was at least 20% less, indicating areas of

















% 43K HP = 45%
Figure 2. The fractional
defect size on the radionuclide image
was measured, averaged for the two views and then
related to the grid distribution of the dot image. A
large anterior wall defect is displayed by this scan.
END DIASTOLE END SYSTOLE
% ACS 42%
Figure 3. Evaluation of the left ventriculogram for the presence
of dyssynergy by superimposition of traced outlines of
the end-diastolic and end-systolic cavitary silhouettes,
Akinetic segments share a common line in systole and
diastole. Dyskinetic segments show paradoxic systolic
expansion. This ventriculogram demonstrates inferior
akinesis and apical dyskinesis.
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Figure 4. The length of dyssynergic segments was measured and ex
pressed as a percentage of the total end-diastolic circum
ference, excluding the aortic valve plane and referred to
as percent abnormally contracting segments (%ACS) . The
area of the 'cold spot' was measured and expressed a per
centage of the total area on the radionuclide scan, % 4^k HP
(hypoperfusion) . In this case, anteroseptal and inferior
defects on the 43K image correspond to anterior hypokinesis
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Figure 5. Large perfusion
defects of the anteroseptal and
inferior walls correspond with anterior and inferior
akinesis on the ventriculogram.
lowest ejection fraction 0.12.
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Figure 7- Regression
curve of End-Diastolic Volume (ordinate)
plotted against the Total Area in the Anterior view
(abscissa) .
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